Theriva Biologics Announces Pricing of $2.5 Million Public Offering
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s[...]
09/23/2024 | Press release | Distributed by Public on 09/23/2024 15:27
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact